Acrospire Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,200	Closed	-$46K	–	2399
2016 Q4	$46K	Buy	1,200 +1,000	+500%	+$38.3K	0.02%	1449
2016 Q3	$10K	Sell	200 -200	-50%	-$10K	0.01%	1701
2016 Q2	$18K	Buy	+400	New	+$18K	0.01%	1565